Related Experiment Video
Updated: Jan 7, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
GAB2 regulates lipid metabolism by activating the MEK/ERK/c-Myc pathway: impact on renal cell carcinoma progression
Weiqun Zhang1, Xianming Fei2, Pinqiong Qin1
1Department of Clinical Laboratory, The First People's Hosiptal of Lin'an District, Hangzhou, 311300, Zhejiang, China.
Background:
Grb2-associated binding protein 2 (GAB2) is a scaffold protein in the cytoplasm involved in the progression of various cancers, but its significance in renal cell carcinoma (RCC) development remains unclear. The investigation sought to explore the mechanisms of GAB2 in RCC.
Methods:
GAB2 mRNA levels were examined in normal renal tubular epithelial cells (HKC) and RCC cell lines (ACHN and OS-RC-2). GAB2 was knocked down or overexpressed in RCC cells, and changes in cell proliferation, apoptosis, migration, and lipid metabolism were assessed. Moreover, p-MEK, p-ERK, and c-Myc levels were measured. The MEK inhibitor U0126 was introduced to validate the underlying mechanisms. Nude mice were subcutaneously injected with ACHN cells transfected with either oe-NC or oe-GAB2 , and then treated with U0126. The MEK/ERK/c-Myc pathway, tumor growth, and lipid metabolism were subsequently evaluated.
Results:
GAB2 expression was notably elevated in RCC cells compared to HKC. GAB2 knockdown markedly reduced RCC cell viability, induced apoptosis, and inhibited cell migration and lipid accumulation, whereas overexpression of GAB2 had the opposite effects. Notably, the MEK/ERK/c-Myc pathway in RCC cells was inhibited by GAB2 knockdown and activated by its overexpression. U0126 treatment altered the effects of GAB2 overexpression in RCC cells. In RCC mice, GAB2 overexpression upregulated MEK/ERK/c-Myc pathway, which was suppressed by U0126. Moreover, GAB2 overexpression promoted tumor growth and lipid synthesis in RCC mice, and U0126 counteracted these changes.
Conclusion:
GAB2 enhances lipid accumulation by activating MEK/ERK/c-Myc pathway, thereby promoting RCC progression. GAB2 is a potential target for RCC management.
Insights
Grb2-associated binding protein 2 (GAB2) promotes renal cell carcinoma (RCC) progression by enhancing lipid accumulation via the MEK/ERK/c-Myc pathway. Targeting GAB2 may offer a new strategy for RCC management.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Grb2-associated binding protein 2 (GAB2) is a cytoplasmic scaffold protein implicated in various cancers.
- Its specific role and mechanisms in renal cell carcinoma (RCC) development are not well understood.
Purpose of the Study:
- To investigate the role and underlying mechanisms of GAB2 in the progression of renal cell carcinoma (RCC).
Main Methods:
- Examined GAB2 mRNA levels in normal renal cells and RCC cell lines.
- Assessed the impact of GAB2 knockdown and overexpression on RCC cell proliferation, apoptosis, migration, and lipid metabolism.
- Evaluated the MEK/ERK/c-Myc pathway activation and tumor growth in vivo using a xenograft mouse model and a MEK inhibitor (U0126).
Main Results:
- GAB2 expression was significantly higher in RCC cells compared to normal cells.
- GAB2 knockdown inhibited RCC cell viability, migration, and lipid accumulation, while inducing apoptosis.
- GAB2 overexpression promoted tumor growth, lipid synthesis, and activated the MEK/ERK/c-Myc pathway, effects partially reversed by U0126.
Conclusions:
- GAB2 promotes RCC progression by activating the MEK/ERK/c-Myc pathway, leading to increased lipid accumulation.
- GAB2 represents a potential therapeutic target for managing renal cell carcinoma.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Master Transcription Regulators
PI3K/mTOR/AKT Signaling Pathway
Mitogens and the Cell Cycle
Abnormal Proliferation